What assessment findings indicate that albuterol/ipratropium treatment was effective for Jack?

The effectiveness of albuterol and ipratropium treatment can be demonstrated through various assessment findings indicative of improved respiratory function. An improved productive cough and absence of dyspnea (difficulty breathing) are strong indicators that the treatment has worked effectively.

Albuterol is a bronchodilator that relaxes the muscles of the airways, leading to widening and improved airflow, while ipratropium helps decrease mucus production and further facilitates breathing. If the patient exhibits a productive cough, it suggests that secretions are being effectively expelled, and the absence of dyspnea indicates that the patient is no longer experiencing difficulty in breathing, which is a primary goal of administering these medications.

Therefore, noting both an improved productive cough and no dyspnea reflects significant progress in the patient’s respiratory status after the treatment.